<4015> PayCloud 611 +2
Continued rise. After the close of trading on the 25th, the company released its monthly performance report for June, which was well received. The main performance indicator, MRR (monthly recurring revenue) growth rate, increased by 118% compared to the same month last year, and the handling amount was 114 billion yen (including online charges of approximately 0.7 billion yen). The cumulative number of IDs is 0.24 million (an increase of approximately 1.5 million from the previous month), and the cumulative number of stores is 123,548 (an increase of 253 from the previous month), showing a strong trend.
<190A> Chordia 715 -13
Although it reached a new high for the year, it fell back. It seems to have attracted buyers due to the fact that SBI Investment submitted a change report (5% rule report) to the Ministry of Finance at the reception desk on the 25th. According to the report, the ownership ratio of Chordia's shares by SBI Investment and joint shareholders has increased from 6.42% to 8.73%. The date of the report obligation is July 18th.
<3930> Hatena 772 +19
It rose significantly. On the 25th, it was announced that the SaaS-type server monitoring service "Mackerel" had been adopted for IDC Frontier's in-memory database "IDCF Cloud CacheDB", provided since the 25th, which is considered a good material. Through the previous cooperation, the "Mackerel" service has been evaluated and adopted. Users can now configure resource monitoring by entering the API key for "Mackerel" when creating a new CacheDB on the "IDCF Cloud" console.
<4592> Sun Bio 1041 +150
It hit the limit up. After the end of trading on the 25th, it was announced that a new patent related to cell therapy for chronic stroke using the major development product "SB623" was granted in the United States, which is considered a good material. The company is trying to build and maintain a patent portfolio as part of maximizing its corporate value, but with this patent acquisition, it was able to significantly extend the period of the usage patent for "SB623" chronic stroke treatment in the largest market, the United States.
<4013> Kinjiro 416 +26
Rapid rise. After the end of trading on the 25th, the upward revision of the performance forecast for the second quarter of the 24 fiscal year ending December has been announced and well received. Revenue was revised from the previous estimate of 2.029 billion yen to 2.068 billion yen (an increase of 1.9%), and operating profit was revised from 0.188 billion yen to 0.281 billion yen (an increase of 49.6%). In the on-premises business, inquiries exceeding expectations continued, software product sales greatly exceeded the plan, and in the cloud business, cloud license sales exceeded the plan. However, the full-year performance forecast remains unchanged from the previous estimate.
<9348> ispace 614 +24
Surging. After the end of trading on the 25th, ispace EUROPE S.A., a European subsidiary, announced that it had completed the assembly of the flight model of the micro-rover (a small lunar rover) designed and manufactured independently for the first time in Luxembourg, where its base is located, which is viewed as good news. The micro-rover will be transported from Luxembourg to Japan, and will be loaded onto the “HAKUTO-R” mission 2 RESILIECE lander (lunar lander) for launch in the winter of 2024.